Clinical analysis of CHD2 gene mutations in pediatric patients with epilepsy
Open Access
- 26 April 2022
- journal article
- research article
- Published by Wiley in Pediatric Investigation
- Vol. 6 (2) , 93-99
Abstract
Importance: CHD2 is a member of the chromodomain helicase DNA‐binding (CHD) family of proteins, which have important roles in the regulation of gene expression. Dysregulation of this protein may lead to various disorders.Objective: To delineate the genotypes and phenotypes of CHD2‐related epilepsy.Methods: We analyzed the medical history, magnetic resonance imaging findings, and video‐electroencephalogram recordings of 17 patients with CHD2 mutations in the Neurology Department of Beijing Children's Hospital from June 2016 to June 2021.Results: Age at seizure onset ranged from 6 months to 10 years; the median age at onset was 4 years. Generalized tonic‐clonic, myoclonic, eyelid myoclonic, atonic, atypical absence, myoclonic‐atonic, and spasm seizures were observed. Ten of the 17 patients had multiple types of seizures. One patient exhibited photosensitivity epilepsy and one patient exhibited grid image‐induced visual reflex epilepsy. Developmental disability was present in 14 patients, while autism features were present in five patients. Sixteen patients had de novo mutations of CHD2; one patient had an inherited variant. Eleven mutations were novel. One patient had two mutations; that patient exhibited development delay and refractory epilepsy. Seizures were controlled in eight patients, improved in seven patients, and resistant to treatment in two patients.Interpretation: Phenotype severity in patients with CHD2 variants ranged from drug‐responsive seizures to severe epileptic encephalopathy. Most patients exhibited developmental disorders.Keywords
Funding Information
- National Natural Science Foundation of China (81301118)
This publication has 28 references indexed in Scilit:
- Human CHD2 Is a Chromatin Assembly ATPase Regulated by Its Chromo- and DNA-binding DomainsJournal of Biological Chemistry, 2015
- De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic EncephalopathiesThe American Journal of Human Genetics, 2014
- 15q26.1 microdeletion encompassing only CHD2 and RGMA in two adults with moderate intellectual disability, epilepsy and truncal obesityEuropean Journal of Medical Genetics, 2014
- CHD2 haploinsufficiency is associated with developmental delay, intellectual disability, epilepsy and neurobehavioural problemsJournal of Neurodevelopmental Disorders, 2014
- De Novo Loss-of-Function Mutations in CHD2 Cause a Fever-Sensitive Myoclonic Epileptic Encephalopathy Sharing Features with Dravet SyndromeThe American Journal of Human Genetics, 2013
- Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing studyThe Lancet, 2012
- Deletion of the RMGA and CHD2 genes in a child with epilepsy and mental deficiencyEuropean Journal of Medical Genetics, 2012
- Functional impact of global rare copy number variation in autism spectrum disordersNature, 2010
- Early onset myoclonic epilepsy and 15q26 microdeletion: Observation of the first caseEpilepsia, 2009
- Analysis of the Electrical Response of the Human Cortex to Photic StimulationNature, 1946